Assessing Techniques to Improve the TME For Therapeutic Discovery & Development

Time: 9:00 am
day: Conference Day One


  • Highlighting the importance of designing tumour models that accurately represent the immune component to effectively evaluate immuno-oncology therapies 
  • Uncovering methods for TME remodelling to promote immune activation 
  • Implementing tumour models including CDX/PDX mice and 3D tissue model systems to assess combination therapies of cancer vaccines with checkpoint inhibitors